Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Germ Cell and Embryonal × Vorinostat × 30 days × Clear all

Sponsor

Conditions

Myelodysplastic Syndromes 2 Leukemia, Myelomonocytic, Chronic 2 Anemia, Refractory, with Excess of Blasts 2 Uveal Melanoma 1 Recurrence 1 Oligodendroglioma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Extranodal NK-T-Cell 1 Leukemia, Myeloid, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 GATA2 Deficiency 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1 Anemia, Refractory 1

Interventions

Etoposide 2 Cyclophosphamide 2 Cisplatin 2 Carboplatin 2 pralsetinib 1 pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 etoposide phosphate 1 Standard of Care 1 Specimen Handling 1 Sirolimus 1 Respiratory Physiological Phenomena 1 Practice Guidelines as Topic 1 Platinum 1 Pemetrexed 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Celecoxib 1 Bleomycin 1 Biopsy 1 130-nm albumin-bound paclitaxel 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡